Hub provides Focal Point for Investment and Growth

The BioHub Birmingham has provided the first physical footprint within the UK and Europe for Infectious disease diagnostics company Genetic Signatures, a provider of testing kits to countries in Europe and of clinical diagnostics to the NHS for respiratory and gastro-intestinal diseases and sexually transmitted infections. 

The localisation of service and support has become a key focus for the company which will now include Field Applications Scientists at its site operations. The BioHub laboratory will support the  development of protocols, processes and quality performance materials that are necessary for  planned growth into new territories in Europe, the Middle East and Africa and also offer customers additional training and technical support opportunities through hands-on learning.

The team is led by Director John Buckels, an infectious diseases veteran who is already based in the UK. “Genetic Signatures has an established customer base in Europe and taking a physical base for these operations is showcasing the commitment of our investment for future growth in the region,” he said.

David Coleman, CEO of University of Birmingham Enterprise, the organisation that manages the BioHub, commented:  “We are delighted to welcome Genetic Signatures to the BioHub Birmingham®.  Our facilities, and access to expertise, makes our location a great destination for healthcare and life science companies seeking to enter the UK market.  We are part of Birmingham Health Partners in a highly connected ecosystem that has been designated by the UK government as a Life Sciences Opportunity Zone, and also includes the Precision Health Technologies Accelerator, which is due to open in 2023.”

More information online